Form Type: 4

SEC EDGAR Link
Acccession Number:0001104659-20-005262
Date:2020-01-16
Issuer: ADAPTIMMUNE THERAPEUTICS PLC (ADAP)
Original Submission Date:

Reporting Person:

TAYTON-MARTIN HELEN KATRINA
C/O ADAPTIMMUNE THERAPEUTICS PLC,
60 JUBILEE AVENUE, MILTON PARK ABINGDON, X0 OX14 4RX

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
OPTION TO PURCHASE ORDINARY SHARES 0.74 2020-01-16 deemed execution date A 1,257,744 (a) 2030-01-16 ordinary shares 1,257,744 $0.74 1,257,744 direct
OPTION TO PURCHASE ORDINARY SHARES 0.0013 2020-01-16 deemed execution date A 280,896 (a) 2030-01-16 ordinary shares 280,896 $0.00 280,896 direct
Footnotes
IDfootnote
f1 the exercise price was converted from gbp0.57 based on an exchange rate of u.s$1.302659 to gbp1.00. the actual exercise price will be the pounds sterling amount.
f2 exercisable as to 314,436 ordinary shares on january 16, 2021 and will be exercisable as to the remainder in monthly installments of 26,202 ordinary shares on the sixteenth of each month from february 16, 2021 through december 16, 2023 and 26,238 ordinary shares on january 16, 2024.
f3 the exercise price was converted from gbp0.001, being the nominal value of an ordinary share, based on an exchange rate of $u.s 1.302659 to gbp1.00. the actual exercise price will be the pounds sterling amount.
f4 exercisable as to 70,224 ordinary shares on january 16, 2021 and will be exercisable as to the remainder in annual installments of 70,224 ordinary shares on january 16, 2022 and january 16, 2023, and 70,224 ordinary shares on january 16, 2024.

Elevate your investments